SCHEMBL23833732

SCHEMBL23833732

O=C(O)c1ncco1.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL287187 0.98
SCHEMBL27894842 0.95
Hydrochloric Acid SCHEMBL10614767 0.95
SCHEMBL27894388 0.95
Formaldehyde SCHEMBL27828588 0.93 CES1 (0.44)
Pyrimidine SCHEMBL29105565 0.86 CES1 (0.43)
Glycine SCHEMBL1987508 0.86 CES1 (0.43)
SCHEMBL28542223 0.86 FAAH (0.50)
Trifluoroacetic Acid SCHEMBL8358514 0.86 CES1 (0.40)
Fluorobenzene SCHEMBL28328929 0.82 CES1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
EP-4121029-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF Amathus Therapeutics, Inc. (US) 2023-01-25 EP disclosed
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed